Lv2
158 积分 2023-11-23 加入
Changes of T Lymphocyte Subsets after CAR-T Cell Therapy and Its Clinical Significance
13天前
已关闭
Changes of T Lymphocyte Subsets after CAR-T Cell Therapy and Its Clinical Significance
13天前
已关闭
Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years
18天前
已完结
Need for standardization of cytokine profiling in CAR T cell therapy
18天前
已完结
Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature
1个月前
已完结
Lenalidomide Treatment of Isolated Central Nervous System Relapse in Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy
2个月前
已完结
Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement
2个月前
已完结
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement
2个月前
已完结
Stereotactic radiotherapy and CART for treatment of secondary CNS lymphoma
2个月前
已完结
CAR T cell combination therapies to treat cancer
2个月前
已完结
皖公网安备34019202002308
